Berry Street, a US-based nutrition startup, has merged with Indian health platform Healthify to capitalize on the rising demand for GLP-1 therapies in weight management. The new entity will leverage AI nutrition coaching and extensive clinical networks to advance metabolic health services globally.
- Merged entity led by co-CEOs Kotlove and Vashisht
- Focus on AI-driven nutrition and GLP-1 metabolic care
- Operations under Berry Street in the US, Healthify in India
What happened
Berry Street, a US nutrition startup, and Healthify, an Indian health platform backed by Khosla Ventures, announced their merger to expand access to GLP-1-based weight loss programs. Financial details of the deal were not disclosed. The companies will be co-led by founders Noah Kotlove of Berry Street and Tushar Vashisht of Healthify. In the US, the combined operation will use the Berry Street brand, while it will continue as Healthify in other markets such as India.
Healthify, which has raised over $150 million, offers AI-enhanced and human fitness and nutrition coaching through a mobile app. It expanded into the US market last year and introduced GLP-1-aided programs for Indian consumers. Berry Street provides insurance-covered care through over 2,000 clinics and raised $50 million last year. Both startups blend AI nutrition tools with clinical expertise, aiming to deliver scalable metabolic health solutions.
Why it matters
The GLP-1 drug category is rapidly growing as millions turn to these medications for weight loss and metabolic health. A JP Morgan report estimates more than 30 million US patients will use GLP-1 therapies by 2030, underlining strong market demand. By merging, Berry Street and Healthify combine their clinical networks, AI capabilities, and regional strengths to address this expanding opportunity more effectively.
The partnership aims to set a new standard for accessible, expert-driven nutrition and metabolic care. Healthify’s AI-driven approach to putting dietitians directly in users’ pockets aligns with Berry Street’s infrastructure to deliver insurance coverage and clinical service at scale. This integrated model could transform how metabolic health and nutrition coaching are delivered across large and diverse populations in both the US and India.
What to watch next
Monitor the merged company's rollout of enhanced GLP-1 and metabolic health programs across the US and Indian markets, including any new partnerships or product innovations leveraging AI and clinical networks. Their ability to scale coverage under insurance plans and expand user adoption will be critical indicators of success.
It will also be significant to see how the combined entity navigates regulatory environments and competition as GLP-1 trends continue. The integration of AI coaching with thousands of clinics offers a blueprint for broader metabolic care innovation, making this merger a trendsetter for future healthtech collaborations internationally.